Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03403283 · ClinicalTrials.gov registry record
Dyslipidemia and Diabetic Retinopathy
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 45
- Enrollment target
NCT03403283: Completed study, sponsored by University of Alabama at Birmingham.
NCT03403283 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03403283 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.
Primary Outcome
Peripheral blood of 150 cc, about 8-10 tablespoons will be collected from vein in the arm of both diabetic and control subjects.ASM activity was measured on a scale of 0-0.6. 0.6 is worse with units being nM/hr
Interventions
- OTHER 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
- OTHER Healthy Controls 15 age matched control subjects
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-01 |
| Est. Completion | 2023-04-30 |
What the finished NCT03403283 record still lists
NCT03403283 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy is the first listed.
NCT03403283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03403283 about?
NCT03403283 is a clinical study titled "Dyslipidemia and Diabetic Retinopathy". The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.
What is the current status of trial NCT03403283?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2014-01. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT03403283?
The interventions under investigation include: 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy (OTHER), Healthy Controls 15 age matched control subjects (OTHER).
Who is sponsoring clinical trial NCT03403283?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia